Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system

S Demaré, A Kothari, NA Calcutt… - Expert review of …, 2021 - Taylor & Francis
Introduction: Metformin is currently first line therapy for type 2 diabetes (T2D). The
mechanism of action of metformin involves activation of AMP-activated protein kinase …

Is metformin a possible treatment for diabetic neuropathy?

J Wei, Y Wei, M Huang, P Wang, S Jia - Journal of Diabetes, 2022 - Wiley Online Library
Metformin is a hypoglycemic drug widely used in the treatment of type 2 diabetes. It has
been proven to have analgesic and neuroprotective effects. Metformin can reverse pain in …

AMPK activator O304 protects against kidney aging through promoting energy metabolism and autophagy

M Zhu, W Shen, J Li, N Jia, Y Xiong, J Miao… - Frontiers in …, 2022 - frontiersin.org
Aging is an important risk factor for kidney injury. Energy homeostasis plays a key role in
retarding aging, and mitochondria are responsible for energy production. In the kidney, renal …

Deficient AMPK activity contributes to hyperexcitability in peripheral nociceptive sensory neurons and thermal hyperalgesia in lupus mice

V Viatchenko-Karpinski, L Kong, HR Weng - Plos one, 2023 - journals.plos.org
Patients with systemic lupus erythematosus (SLE) often suffer from chronic pain. Little is
known about the peripheral mechanisms underlying the genesis of chronic pain induced by …

Emerging Molecular and Synaptic Targets for the Management of Chronic Pain Caused by Systemic Lupus Erythematosus

HR Weng - International Journal of Molecular Sciences, 2024 - mdpi.com
Patients with systemic lupus erythematosus (SLE) frequently experience chronic pain due to
the limited effectiveness and safety profiles of current analgesics. Understanding the …

Pivotal role of the gut microbiota in congenital insensitivity to pain with anhidrosis

M Zhang, Y Hong, W Wu, N Li, B Liu, J Sun, X Cao… - …, 2021 - Springer
Background Increasing evidence has shown that the occurrence and development of
various human diseases are closely related to the gut microbiota. We compared the gut …

What's new in chronic pain pathophysiology

I Cohen, MJ Lema - Canadian Journal of Pain, 2020 - Taylor & Francis
The understanding of pain pathophysiology is continuously evolving. Identifying underlying
cellular and subcellular pathways helps create opportunities for targeted therapies that may …

AMP-activated protein kinase (AMPK) activator drugs reduce mechanical allodynia in a mouse model of low back pain

V Das, JS Kroin, M Moric, RJ McCarthy… - Regional Anesthesia & …, 2019 - rapm.bmj.com
Background and objectives Intervertebral disc herniation is one of the common causes of
low back pain. Adenosine monophosphate (AMP)-activated protein kinase (AMPK) activator …

Analgesic Effectiveness and Dorsal Root Ganglia Protein Modulation of a Peripheral Adenosine Monophosphate Kinase Alpha Activator (O304) Following Lumbar …

V Das, MB Basovich, JS Kroin… - Anesthesia & …, 2022 - journals.lww.com
BACKGROUND: Disk herniation is a primary cause of radicular back pain. The purpose of
this study was to evaluate the antiallodynic effective dose in 50% of the sample (ED 50) and …

二甲双胍治疗糖尿病周围神经病变——有益还是有害?

J Wei, Y Wei, M Huang, P Wang, S Jia - Journal of Diabetes, 2022 - search.proquest.com
摘要二甲双胍是一种广泛用于治疗2 型糖尿病的降糖药物. 它已被证明具有镇痛和神经保护作用.
二甲双胍可以逆转啮齿类动物的疼痛, 如糖尿病性神经痛, 化疗药物引起的神经性疼痛 …